Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34914175)
Watch
English
Thalidomide treatment in multiple myeloma
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Thalidomide treatment in multiple myeloma
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
main subject
thalidomide
0 references
author name string
Kathrin Strasser
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
Heinz Ludwig
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
publication date
1 December 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
published in
Blood Reviews
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
volume
16
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
page(s)
207-215
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
issue
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
cites work
THALIDOMIDE AND CONGENITAL ABNORMALITIES
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumor activity of thalidomide in refractory multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enantioselective inhibition of TNF-alpha release by thalidomide and thalidomide-analogues
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous formulations of the enantiomers of thalidomide: pharmacokinetic and initial pharmacodynamic characterization in man.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Embryotoxic effects of thalidomide derivatives in the non-human primate callithrix jacchus. IV. Teratogenicity of micrograms/kg doses of the EM12 enantiomers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide is an inhibitor of angiogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of thalidomide on experimental tumors and metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
THALIDOMIDE (N-PHTHALOYLGLUTAMIMIDE) IN THE TREATMENT OF ADVANCED CANCER.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide for previously untreated indolent or smoldering multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide and dexamethasone combination for refractory multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic application of thalidomide in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide in the management of multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thalidomide analogs and PDE4 inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0268-960X%2802%2900031-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0268-960X(02)00031-0
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
PubMed ID
12350364
1 reference
stated in
Europe PubMed Central
PubMed ID
12350364
retrieved
5 August 2017
ResearchGate publication ID
11106691
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
